Cell2Cure ApS will provide patients, physicians and health care systems around the word with easy to use “off-the-shelf” highly effective and safe stem cell products for the treatment of patients with a wide range of diseases. Cell2Cure is developing stem cell products, that are applied in promising new therapeutic concepts for treatment of several diseases. Pre-clinical studies and clinical phase I and II trials have demonstrated that our stem cell product can be used for treatment of heart diseases and tissue regeneration. Cell2Cure stem cell products are being clinically tested in a wide range of disease indications, where inflammation and tissue regeneration plays a role, and in prevention of organ transplant rejection.
View Top Employees from Cell2Cure ApSWebsite | https://cell2cure.com/ |
Employees | 7 (3 on RocketReach) |
Founded | 2018 |
Address | 9 Kajerødgård, Birkerød 3460, DK |
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Cell2Cure ApS employee's phone or email?
Mandana Haack-Sørensen is the Management Director of Cell2Cure ApS.
3 people are employed at Cell2Cure ApS.
The NAICS codes for Cell2Cure ApS are [325, 3254, 32].
The SIC codes for Cell2Cure ApS are [283, 80, 28].